CAS: 1384260-65-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Aducanumab REF: TM-T77042CAS: 1384260-65-4 | SDS-PAGE:97.3%;SEC-HPLC:97.1% | To inquire | Tue 07 Jan 25 |
 | Aducanumab REF: 3D-CLA1343CAS: 1384260-65-4 | - - - | To inquire | Wed 15 Jan 25 |
Aducanumab
CAS:1384260-65-4
Aducanumab (BIIB037) is an IgG1 antibody targeting amyloid beta to treat Alzheimer's; it's brain-permeable.
Purity:
SDS-PAGE:97.3%;SEC-HPLC:97.1%
Color and Shape:
Liquid
Molecular weight:
145.93 kDa
Ref: TM-T77042
| 1mg | 176.00 € | ||
| 5mg | 444.00 € | ||
| 10mg | 755.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 3D-CLA1343
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
